Plenary Sessions
Plenary Session #1 – From Evidence to Decision: Barriers and Solutions
- John Abbott, CEO, Health Council of Canada
- Dr. Paul Hébert, Editor-in-chief, Canadian Medical Association Journal
- Dr. Janet Martin, Director, High Impact Technology Evaluation Centre
Plenary Session #2 – Models for Public Engagement
- Dr. Ghislaine Cleret de Langavant, Deputy Health Commissioner Responsible for Ethics, Quebec Health and Welfare
- Dr. Lisa Dolovich, Associate Professor, Department of Family Medicine, McMaster University and Chair, COMPUS Expert Review Committee and Cathy MacNutt, Public Member, COMPUS Expert Review Committee
- Dr. Sharon Manson Singer, President, Canadian Policy Research Networks
Plenary Session #3 – Real World Evidence – Filling the Knowledge Gaps
- Dr. Diane Forbes, associate Director, Drug Safety and Effectiveness, Canadian Institutes of Health Research
- David K. Lee, Director, Office of Legislative and Regulatory Modernization, Health Canada
- Penny Mohr, Vice-President for Programs, Center for Medical Technology
- Cynthia Sunstrum, Manager, Drug Safety and Effectiveness Network (DSEN) Project, Health Canada